Acorda Therapeutics, Inc (ACOR)

Etorro trading 970x250
Acorda Therapeutics, Inc (ACOR) Logo

About Acorda Therapeutics, Inc

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol dependence; and Inbrija for the treatment of OFF periods in Parkinson’s disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York. Address: 420 Saw Mill River Road, Ardsley, NY, United States, 10502

Acorda Therapeutics, Inc News and around…

Latest news about Acorda Therapeutics, Inc (ACOR) common stock and company :

Analysts Predict 22% Gains Ahead For IEIH
29 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Evolved US.

12 Health Care Stocks Moving In Wednesday's After-Market Session
17 Nov, 2021 FinancialContent

Gainers Rani Therapeutics Hldgs (NASDAQ:RANI) stock rose 7.36% to $35.0 during Wednesday's after-market session. The ...

Acorda Inks Distribution Pact In Germany For Inhaled Levodopa Powder; Q3 Earnings Beat Expectations
10 Nov, 2021 FinancialContent

Acorda Therapeutics Inc(NASDAQ: ACOR)entered into distribution and supply agreementswithEsteve ...

Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
09 Nov, 2021 FinancialContent

Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany

Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
09 Nov, 2021 FinancialContent

Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team

Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
02 Nov, 2021 FinancialContent

Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021

12 Health Care Stocks Moving In Friday's Pre-Market Session
22 Oct, 2021 FinancialContent

Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
22 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Happy Friday, trader! The week's almost done and we're starting off the final day of it with a look at the biggest pre-market stock movers! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

12 Health Care Stocks Moving In Friday's Intraday Session
24 Sep, 2021 FinancialContent

Gainers Molecular Templates (NASDAQ:MTEM) stock rose 14.13% to $7.59 during Friday's regular session. Trading volume ...

Analysts Forecast 18% Upside For IEIH
22 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Evolved US.

Acorda Therapeutics Announces Corporate Restructuring, Management Changes
09 Sep, 2021 FinancialContent

Acorda Therapeutics Announces Corporate Restructuring, Management Changes

Return on Capital Employed Insights for Acorda Therapeutics
26 Aug, 2021 FinancialContent

After pulling data from Benzinga Pro it seems like during Q2, Acorda Therapeutics (NASDAQ:ACOR) posted sales of $31.79 million. ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
26 Aug, 2021 FinancialContent

Gainers Ascendis Pharma (NASDAQ:ASND) stock increased by 22.69% to $151.73 during Thursday's pre-market session. The ...

84 Biggest Movers From Friday
09 Aug, 2021 FinancialContent

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with ...

Acorda Therapeutics (ACOR) Reports Q2 Loss, Tops Revenue Estimates
05 Aug, 2021 Yahoo! Finance

Acorda (ACOR) delivered earnings and revenue surprises of -9.57% and 6.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Acorda Therapeutics Reports Second Quarter 2021 Financial Results
05 Aug, 2021 FinancialContent

Acorda Therapeutics Reports Second Quarter 2021 Financial Results

Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
30 Jul, 2021 FinancialContent

Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021

Will Acorda Therapeutics (ACOR) Report Negative Q2 Earnings? What You Should Know
27 Jul, 2021 Yahoo! Finance

Acorda (ACOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

12 Health Care Stocks Moving In Monday's Pre-Market Session
26 Jul, 2021 FinancialContent

Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The ...

40 Stocks Moving in Monday's Pre-Market Session
26 Jul, 2021 FinancialContent

Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on ...

75 Biggest Movers From Friday
26 Jul, 2021 FinancialContent

Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired ...

12 Health Care Stocks Moving In Friday's After-Market Session
23 Jul, 2021 FinancialContent

Gainers NanoVibronix (NASDAQ:NAOV) shares rose 21.45% to $3.17 during Friday's after-market session. This security traded at a ...

50 Stocks Moving In Friday's Mid-Day Session
23 Jul, 2021 FinancialContent

Gainers Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume. The New Home Company ...

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
23 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Acorda Therapeutics Shares Gains On Spain Distribution Pact For Parkinson's Med
23 Jul, 2021 FinancialContent

Acorda Therapeutics Inc(NASDAQ: ACOR)has entered into distribution and supply agreementswithEsteve ...

32 Stocks Moving in Friday's Pre-Market Session
23 Jul, 2021 FinancialContent

Gainers Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported ...

12 Stocks Moving In Thursday's After-Hours Session
22 Jul, 2021 FinancialContent

Gainers Twitter (NYSE: TWTR) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results ...

12 Health Care Stocks Moving In Thursday's After-Market Session
22 Jul, 2021 FinancialContent

Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 25.26% to $2.33 during Thursday's after-market session. Today's trading volume ...

Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain
22 Jul, 2021 FinancialContent

Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain

Hedge Funds Are Buying Acorda Therapeutics Inc (ACOR) Again
19 Jun, 2021 Yahoo! Finance

The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]

Acorda Therapeutics, Inc (ACOR) is a NASDAQ Common Stock listed in , ,

970x250